Data-Driven Technology Re-establishes a Pathway for Antibody Genus Claims that Meet US Patent Requirements PHILADELPHIA, April 21, 2026 /PRNewswire/ -- Integral Molecular, the industry leader in the ...
Paratope-PLUS™ involves mutating each residue of an antibody's CDRs (Complementarity Determining Regions) to all 19 other amino acids, identifying every variant that retains or enhances function. This ...
Integral Molecular, the industry leader in the discovery and engineering of antibodies against membrane proteins, announces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results